DATE,PATIENT,ENCOUNTER,CODE,DESCRIPTION,BASE_COST
2017-02-15T14:50:36Z,fe9630ac-ad70-5ce2-9838-468cd0e6df3a,0c3fd317-2e3b-b80f-d4d9-cd206ceec1a0,140,Influenza  seasonal  injectable  preservative free,136.0
2017-02-15T14:50:36Z,fe9630ac-ad70-5ce2-9838-468cd0e6df3a,0c3fd317-2e3b-b80f-d4d9-cd206ceec1a0,113,Td (adult)  5 Lf tetanus toxoid  preservative free  adsorbed,136.0
2017-02-15T14:50:36Z,fe9630ac-ad70-5ce2-9838-468cd0e6df3a,0c3fd317-2e3b-b80f-d4d9-cd206ceec1a0,43,Hep B  adult,136.0
2017-02-15T14:50:36Z,fe9630ac-ad70-5ce2-9838-468cd0e6df3a,0c3fd317-2e3b-b80f-d4d9-cd206ceec1a0,114,meningococcal MCV4P,136.0
2019-10-16T14:50:36Z,fe9630ac-ad70-5ce2-9838-468cd0e6df3a,df865951-1366-d8ad-4f10-cda569658376,140,Influenza  seasonal  injectable  preservative free,136.0
2020-02-19T14:50:36Z,fe9630ac-ad70-5ce2-9838-468cd0e6df3a,919aba09-89bc-61d9-f5d7-96a814336d5c,140,Influenza  seasonal  injectable  preservative free,136.0
2021-04-28T14:50:36Z,fe9630ac-ad70-5ce2-9838-468cd0e6df3a,0e9478fb-e0af-e7cc-5a48-2a080244f42e,208,COVID-19  mRNA  LNP-S  PF  30 mcg/0.3 mL dose,136.0
2021-05-19T14:50:36Z,fe9630ac-ad70-5ce2-9838-468cd0e6df3a,5dee5319-e6ea-6c0c-5eb7-4ca82f59442c,208,COVID-19  mRNA  LNP-S  PF  30 mcg/0.3 mL dose,136.0
2023-02-22T14:50:36Z,fe9630ac-ad70-5ce2-9838-468cd0e6df3a,a3abc8d4-4b0d-3fc6-240b-b1e905aad9bb,140,Influenza  seasonal  injectable  preservative free,136.0
